In North America, hepatocellular carcinoma (HCC) is one of only a few malignancies with an increasing incidence in recent years.[1]
Kelly W. Burak, MD, FRCPC, MSc (Epid)
Advertisement
Articles by Kelly W. Burak, MD, FRCPC, MSc (Epid)
Advertisement
Latest Updated Articles
- Candidacy for Sorafenib in HCC Patients: Is There a Slippery Slope
Published: March 17th 2011 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Sac-TMT Combo Produces Encouraging Activity in Pretreated Metastatic CRPC
2
Zurletrectinib Generates Responses in Advanced NTRK Fusion Solid Tumors
3
FDA Grants Interchangeability Designation to 2 Denosumab Biosimilars
4
Molecular Insights Into Cancer Cachexia: An Evolution in Identifying the Syndrome
5
